1. 講題:
A Phase 1 Cohort Expansion Trial of OBI-833 in Non-Small Cell Lung Cancer Patients 報告編序:397P,海報編號:ID-680 報告人:何景良醫師、三軍總醫院癌症中心主任 報告類別:電子海報展示─胸腔腫瘤、轉移性
時間:2020 年 11 月 20 日(周五)
相關資訊請連結:
https://cslide.ctimeetingtech.com/asia2020/attendee/confcal/show/session/87#presentati on-abstract-6801974474295
2. 講題:
OBI-833 was safe and immunogenic, without treatment-related SAEs, in a Phase 1 dose- escalation
報告編號:71MO
報告人:台北醫學大學附設醫院癌症試驗房主任夏和雄醫師(現任職台北慈濟醫院)
報告類別:微型口頭報告─發展與精準醫學
時間:2020年11月20日19:52-19:57
相關資訊請連結:
https://cslide.ctimeetingtech.com/asia2020/attendee/confcal/show/session/64#presentati on-abstract-798375249763
Esmo asia-virtual-congress-obi-833 dose escalation final









-
What to Upload to SlideShare
by SlideShare
5094249 views
-
Customer Code: Creating a Company C…
by HubSpot
3834869 views
-
Be A Great Product Leader (Amplify,…
by Adam Nash
854150 views
-
Trillion Dollar Coach Book (Bill Ca…
by Eric Schmidt
1020418 views
-
APIdays Paris 2019 – Innovation @ s…
by apidays
1117192 views
-
A few thoughts on work life-balance
by Wim Vanderbauwhede
896964 views